Suchergebnisse - "Bourdette, Dennis"

PubPharm (363)

1

The Challenges of Treating Late-Onset Multiple Sclerosis

enthalten in: Neurology | 2024

von Bourdette, D. | Wooliscroft, L.

2

Rituximab for Multiple Sclerosis : Hiding in Plain Sight

enthalten in: Neurology | 2024

von Langer-Gould, A. | Sotirchos, E. | Bourdette, D.

3

What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?

enthalten in: Neurology | 2023

von Bourdette, D. | Silbermann, E.

CommentOn: Neurology. 2023 Nov 14;101(20):e2035-e2042. - PMID 37852786

4

Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies

enthalten in: Current neurology and neuroscience reports | 2023

von Chapman, W. | Herink, M. | Cameron, M. | +1

5

Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies

enthalten in: Current neurology and neuroscience reports | 2023

von Chapman, W. | Herink, M. | Cameron, M. | +1

6

Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies

enthalten in: Current neurology and neuroscience reports | 2023

von Chapman, W. | Herink, M. | Cameron, M. | +1

7

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS) : a multicentre, randomised, single-blind, phase 4, non-inferiority trial

enthalten in: The Lancet. Neurology | 2023

von Corboy, J. | Fox, R. | Kister, I. | +25

CommentIn: Lancet Neurol. 2023 Jul;22(7):543-545. - PMID 37353269

8

Polypharmacy in multiple sclerosis : More is not necessarily better

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2023

von Bourdette, D. | Herink, M.

CommentOn: Mult Scler. 2023 Jan;29(1):107-118. - PMID 36301629

9

Protocol for an exploratory, randomised, single-blind clinical trial of aerobic exercise to promote remyelination in multiple sclerosis

enthalten in: BMJ open | 2023

von Wooliscroft, L. | McCoy, S. | Hildebrand, A. | +6

10

Polypharmacy in Multiple Sclerosis : Prevalence, Risks, and Mitigation Strategies

enthalten in: Current neurology and neuroscience reports | 2023

von Chapman, W. | Herink, M. | Cameron, M. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]